These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
13. Hypertensive cerebral hemorrhage with undetectable plasma vascular endothelial growth factor levels in a patient receiving intravitreal injection of aflibercept for bilateral diabetic macular edema: a case report. Yoshimoto M; Takeda N; Yoshimoto T; Matsumoto S J Med Case Rep; 2021 Jul; 15(1):403. PubMed ID: 34311786 [TBL] [Abstract][Full Text] [Related]
14. The Influence of Intravitreal Ranibizumab on Inflammation-associated Cytokine Concentrations in Eyes With Diabetic Macular Edema. Lim SW; Bandala-Sanchez E; Kolic M; Rogers SL; McAuley AK; Lim LL; Wickremasinghe SS Invest Ophthalmol Vis Sci; 2018 Nov; 59(13):5382-5390. PubMed ID: 30452591 [TBL] [Abstract][Full Text] [Related]
15. A Comparison Study of Ranibizumab and Aflibercept in Patients with Naive Diabetic Macular Edema in Presence of Serous Retinal Detachment. Kaldırım H; Yazgan S; Kırgız A; Atalay K; Savur F Curr Eye Res; 2019 Sep; 44(9):987-993. PubMed ID: 30983426 [No Abstract] [Full Text] [Related]
16. Effects of intravitreal injection of ranibizumab on choroidal structure and blood flow in eyes with diabetic macular edema. Okamoto M; Yamashita M; Ogata N Graefes Arch Clin Exp Ophthalmol; 2018 May; 256(5):885-892. PubMed ID: 29492689 [TBL] [Abstract][Full Text] [Related]
17. VEGF-A gene polymorphisms and responses to intravitreal ranibizumab treatment in patients with diabetic macular edema. Tetikoğlu M; Yüksel Z; Aktas S; Sağdik HM; Özcura F Int Ophthalmol; 2018 Dec; 38(6):2381-2388. PubMed ID: 29030794 [TBL] [Abstract][Full Text] [Related]
19. Effectiveness of Intravitreal Ranibizumab for Diabetic Macular Edema with Serous Retinal Detachment. Kaya M; Karahan E; Ozturk T; Kocak N; Kaynak S Korean J Ophthalmol; 2018 Aug; 32(4):296-302. PubMed ID: 30091308 [TBL] [Abstract][Full Text] [Related]
20. Plasma levels of vascular endothelial growth factor before and after intravitreal injection of bevacizumab, ranibizumab and pegaptanib in patients with age-related macular degeneration, and in patients with diabetic macular oedema. Zehetner C; Kirchmair R; Huber S; Kralinger MT; Kieselbach GF Br J Ophthalmol; 2013 Apr; 97(4):454-9. PubMed ID: 23385630 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]